|
|
||||||||
1 Department of Medicine and
2 Program in Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605-2324, USA
Reprint requests to: Ravindra N. Singh, Department of Medicine (LRB 326), University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605-2324, USA; e-mail: Ravindra.Singh{at}umassmed.edu; fax: (508) 856-6797.
Humans have two near identical copies of the survival of motor neuron (SMN) gene, SMN1 and SMN2. In spinal muscular atrophy (SMA), SMN2 is not able to compensate for the loss of SMN1 due to an inhibitory mutation at position 6 (C6U mutation in transcript) of exon 7. We have recently shown that C6U creates an extended inhibitory context (Exinct) that causes skipping of exon 7 in SMN2. Previous studies have shown that an exonic splicing enhancer associated with Tra2 (Tra2-ESE) is required for exon 7 inclusion in both SMN1 and SMN2. Here we describe the method of in vivo selection that determined the position-specific role of wild-type nucleotides within the entire exon 7. Our results confirmed the existence of Exinct and revealed the presence of an additional inhibitory tract (3'-Cluster) near the 3'-end of exon 7. We also demonstrate that a single nucleotide substitution at the last position of exon 7 improves the 5' splice site (ss) such that the presence of inhibitory elements (Exinct as well as the 3'-Cluster) and the absence of Tra2-ESE no longer determined exon 7 usage. Our results suggest that the evolutionary conserved weak 5' ss may serve as a mechanism to regulate exon 7 splicing under different physiological contexts. This is the first report in which a functional selection method has been applied to analyze the entire exon. This method offers unparallel advantage for determining the relative strength of splice sites, as well as for identifying the novel exonic cis-elements.
Keywords: SMN; alternative splicing; in vivo selection; SMA
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. J. Hertel Combinatorial Control of Exon Recognition J. Biol. Chem., January 18, 2008; 283(3): 1211 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xiao, Z. Wang, M. Jang, and C. B. Burge Coevolutionary networks of splicing cis-regulatory elements PNAS, November 20, 2007; 104(47): 18583 - 18588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sumner Molecular Mechanisms of Spinal Muscular Atrophy J Child Neurol, August 1, 2007; 22(8): 979 - 989. [Abstract] [PDF] |
||||
![]() |
T. Kashima, N. Rao, and J. L. Manley An intronic element contributes to splicing repression in spinal muscular atrophy PNAS, February 27, 2007; 104(9): 3426 - 3431. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Singh, R. N. Singh, and E. J. Androphy Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes Nucleic Acids Res., January 28, 2007; 35(2): 371 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Singh, N. N. Singh, E. J. Androphy, and R. N. Singh Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron Mol. Cell. Biol., February 15, 2006; 26(4): 1333 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Q. Xu and W. Mattox Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies Hum. Mol. Genet., January 15, 2006; 15(2): 329 - 336. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |